img

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Insights, Forecast to 2034

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is a preventive biological product developed to protect pigs, particularly swine in the agricultural industry, from the PRRS virus. PRRS is a significant disease affecting pigs, causing reproductive issues in sows and respiratory problems in young and growing pigs. The vaccine is designed to stimulate the pig's immune system to recognize and defend against the PRRS virus, reducing the severity of the disease's impact and preventing its transmission within swine populations.
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market is expected to reach to US$ 1197 million in 2024, with a positive growth of %, compared with US$ 1128 million in 2022. Backed with the increasing demand from downstream industries, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) industry is evaluated to reach US$ 1533 million in 2029. The CAGR will be 4.2% during 2024 to 2029.
Globally, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) key manufacturers include CNADC, Boehringer-Ingelheim, MSD Animal Health, Sinopharm, Ceva, Chengdu Tianbang Biological Products Co., Ltd., Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health and Guangdong Wens Dahuanong Biotechnology Co., Ltd., etc. CNADC, Boehringer-Ingelheim, MSD Animal Health are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market and estimated to attract more attentions from industry insiders and investors.
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) can be divided into Live Vaccine and Inactivated Vaccine, etc. Live Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is widely used in various fields, such as Government Tender and Marketing, etc. Government Tender provides greatest supports to the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) industry development. In 2022, global % sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) went into Government Tender filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CNADC
Boehringer-Ingelheim
MSD Animal Health
Sinopharm
Ceva
Chengdu Tianbang Biological Products Co., Ltd.
Tianjin Ruipu Biological Technology Co., Ltd.
Qilu Animal Health
Guangdong Wens Dahuanong Biotechnology Co., Ltd.
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tiankang
Zoetis
Guangdong Yongshun Biological Pharmaceutical Co Ltd
Plec Bioengineering Co., Ltd.
Segment by Type
Live Vaccine
Inactivated Vaccine

Segment by Application


Government Tender
Marketing

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) plant distribution, commercial date of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) introduction, etc. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Market by Application
1.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Government Tender
1.3.3 Marketing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Estimates and Forecasts 2018-2029
2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region
2.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2018-2024)
2.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2024-2029)
2.2.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2018-2029)
2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Estimates and Forecasts 2018-2029
2.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
2.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2018-2024)
2.4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2029)
2.4.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Manufacturers
3.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Manufacturers (2018-2024)
3.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in 2022
3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Manufacturers
3.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Manufacturers (2018-2024)
3.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue in 2022
3.3 Global Key Players of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Product Offered and Application
3.8 Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type
4.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historical Sales by Type (2018-2024)
4.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Sales by Type (2024-2029)
4.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2018-2029)
4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type
4.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historical Revenue by Type (2018-2024)
4.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2018-2029)
4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type
4.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2018-2024)
4.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application
5.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historical Sales by Application (2018-2024)
5.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Sales by Application (2024-2029)
5.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2018-2029)
5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application
5.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historical Revenue by Application (2018-2024)
5.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2018-2029)
5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application
5.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2018-2024)
5.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
6.1.1 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2029)
6.1.2 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2029)
6.2 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
6.2.1 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2029)
6.2.2 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2029)
6.3 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
6.3.1 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2018-2029)
6.3.3 US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
7.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2029)
7.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2029)
7.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
7.2.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2029)
7.2.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2029)
7.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
7.3.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2018-2029)
7.3.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size
8.1.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (2018-2029)
8.1.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2018-2029)
8.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
8.2.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2029)
8.2.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
9.1.1 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2029)
9.1.2 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2029)
9.2 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
9.2.1 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2029)
9.2.2 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2029)
9.3 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
9.3.1 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2018-2029)
9.3.3 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
10.1.1 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
10.2.1 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
10.3.1 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CNADC
11.1.1 CNADC Company Information
11.1.2 CNADC Overview
11.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CNADC Recent Developments
11.2 Boehringer-Ingelheim
11.2.1 Boehringer-Ingelheim Company Information
11.2.2 Boehringer-Ingelheim Overview
11.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer-Ingelheim Recent Developments
11.3 MSD Animal Health
11.3.1 MSD Animal Health Company Information
11.3.2 MSD Animal Health Overview
11.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MSD Animal Health Recent Developments
11.4 Sinopharm
11.4.1 Sinopharm Company Information
11.4.2 Sinopharm Overview
11.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sinopharm Recent Developments
11.5 Ceva
11.5.1 Ceva Company Information
11.5.2 Ceva Overview
11.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ceva Recent Developments
11.6 Chengdu Tianbang Biological Products Co., Ltd.
11.6.1 Chengdu Tianbang Biological Products Co., Ltd. Company Information
11.6.2 Chengdu Tianbang Biological Products Co., Ltd. Overview
11.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments
11.7 Tianjin Ruipu Biological Technology Co., Ltd.
11.7.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Information
11.7.2 Tianjin Ruipu Biological Technology Co., Ltd. Overview
11.7.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments
11.8 Qilu Animal Health
11.8.1 Qilu Animal Health Company Information
11.8.2 Qilu Animal Health Overview
11.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Qilu Animal Health Recent Developments
11.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
11.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
11.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Overview
11.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments
11.10 CAVAC
11.10.1 CAVAC Company Information
11.10.2 CAVAC Overview
11.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CAVAC Recent Developments
11.11 Komipharm
11.11.1 Komipharm Company Information
11.11.2 Komipharm Overview
11.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Komipharm Recent Developments
11.12 Agrovet
11.12.1 Agrovet Company Information
11.12.2 Agrovet Overview
11.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Agrovet Recent Developments
11.13 Bioveta
11.13.1 Bioveta Company Information
11.13.2 Bioveta Overview
11.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Bioveta Recent Developments
11.14 Jinyu Bio-Technology
11.14.1 Jinyu Bio-Technology Company Information
11.14.2 Jinyu Bio-Technology Overview
11.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Jinyu Bio-Technology Recent Developments
11.15 Phibro Animal Health
11.15.1 Phibro Animal Health Company Information
11.15.2 Phibro Animal Health Overview
11.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Phibro Animal Health Recent Developments
11.16 Tiankang
11.16.1 Tiankang Company Information
11.16.2 Tiankang Overview
11.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Tiankang Recent Developments
11.17 Zoetis
11.17.1 Zoetis Company Information
11.17.2 Zoetis Overview
11.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zoetis Recent Developments
11.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
11.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
11.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Overview
11.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments
11.19 Plec Bioengineering Co., Ltd.
11.19.1 Plec Bioengineering Co., Ltd. Company Information
11.19.2 Plec Bioengineering Co., Ltd. Overview
11.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Plec Bioengineering Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Chain Analysis
12.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Mode & Process
12.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Marketing
12.4.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Channels
12.4.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors
12.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers
13 Market Dynamics
13.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
13.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Drivers
13.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
13.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
14 Key Findings in The Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Live Vaccine
Table 3. Major Manufacturers of Inactivated Vaccine
Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2018-2024)
Table 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2024-2029)
Table 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2018-2024) & (K Units)
Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2029) & (K Units)
Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2018-2024)
Table 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2024-2029)
Table 15. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Manufacturers (2018-2024)
Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2022)
Table 23. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Product Offered and Application
Table 25. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2024) & (K Units)
Table 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2029) & (K Units)
Table 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Type (2018-2024)
Table 30. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Type (2024-2029)
Table 31. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Type (2018-2024)
Table 34. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Type (2024-2029)
Table 35. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2024) & (K Units)
Table 38. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2029) & (K Units)
Table 39. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Application (2018-2024)
Table 40. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Application (2024-2029)
Table 41. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Application (2018-2024)
Table 44. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Application (2024-2029)
Table 45. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2029) & (K Units)
Table 60. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2024) & (K Units)
Table 61. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2029) & (K Units)
Table 62. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2024) & (K Units)
Table 65. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2029) & (K Units)
Table 66. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2018-2024) & (K Units)
Table 72. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2029) & (K Units)
Table 73. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2024) & (K Units)
Table 74. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2029) & (K Units)
Table 75. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2024) & (K Units)
Table 78. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2029) & (K Units)
Table 79. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2024) & (K Units)
Table 82. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2029) & (K Units)
Table 83. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2024) & (K Units)
Table 86. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2029) & (K Units)
Table 87. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2018-2024) & (K Units)
Table 93. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2029) & (K Units)
Table 107. CNADC Company Information
Table 108. CNADC Description and Major Businesses
Table 109. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CNADC Recent Developments
Table 112. Boehringer-Ingelheim Company Information
Table 113. Boehringer-Ingelheim Description and Major Businesses
Table 114. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Boehringer-Ingelheim Recent Developments
Table 117. MSD Animal Health Company Information
Table 118. MSD Animal Health Description and Major Businesses
Table 119. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. MSD Animal Health Recent Developments
Table 122. Sinopharm Company Information
Table 123. Sinopharm Description and Major Businesses
Table 124. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sinopharm Recent Developments
Table 127. Ceva Company Information
Table 128. Ceva Description and Major Businesses
Table 129. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Ceva Recent Developments
Table 132. Chengdu Tianbang Biological Products Co., Ltd. Company Information
Table 133. Chengdu Tianbang Biological Products Co., Ltd. Description and Major Businesses
Table 134. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Chengdu Tianbang Biological Products Co., Ltd. Recent Developments
Table 137. Tianjin Ruipu Biological Technology Co., Ltd. Company Information
Table 138. Tianjin Ruipu Biological Technology Co., Ltd. Description and Major Businesses
Table 139. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments
Table 142. Qilu Animal Health Company Information
Table 143. Qilu Animal Health Description and Major Businesses
Table 144. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Qilu Animal Health Recent Developments
Table 147. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
Table 148. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Major Businesses
Table 149. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments
Table 152. CAVAC Company Information
Table 153. CAVAC Description and Major Businesses
Table 154. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CAVAC Recent Developments
Table 157. Komipharm Company Information
Table 158. Komipharm Description and Major Businesses
Table 159. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Komipharm Recent Developments
Table 162. Agrovet Company Information
Table 163. Agrovet Description and Major Businesses
Table 164. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Agrovet Recent Developments
Table 167. Bioveta Company Information
Table 168. Bioveta Description and Major Businesses
Table 169. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Bioveta Recent Developments
Table 172. Jinyu Bio-Technology Company Information
Table 173. Jinyu Bio-Technology Description and Major Businesses
Table 174. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Jinyu Bio-Technology Recent Developments
Table 177. Phibro Animal Health Company Information
Table 178. Phibro Animal Health Description and Major Businesses
Table 179. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Phibro Animal Health Recent Developments
Table 182. Tiankang Company Information
Table 183. Tiankang Description and Major Businesses
Table 184. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Tiankang Recent Developments
Table 187. Zoetis Company Information
Table 188. Zoetis Description and Major Businesses
Table 189. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Zoetis Recent Developments
Table 192. Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
Table 193. Guangdong Yongshun Biological Pharmaceutical Co Ltd Description and Major Businesses
Table 194. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 195. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments
Table 197. Plec Bioengineering Co., Ltd. Company Information
Table 198. Plec Bioengineering Co., Ltd. Description and Major Businesses
Table 199. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 200. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Plec Bioengineering Co., Ltd. Recent Developments
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
Table 205. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers List
Table 206. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Trends
Table 207. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Drivers
Table 208. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
Table 209. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Picture
Figure 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Type in 2022 & 2029
Figure 4. Live Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Application in 2022 & 2029
Figure 8. Government Tender
Figure 9. Marketing
Figure 10. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Report Years Considered
Figure 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2018-2029 (US$ Million)
Figure 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2018-2029)
Figure 15. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2018-2029 ((K Units)
Figure 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales YoY (2018-2029) & (K Units)
Figure 22. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in the World: Market Share by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue in 2022
Figure 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2018-2029)
Figure 31. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2018-2029)
Figure 32. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2018-2029)
Figure 33. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Country (2018-2029)
Figure 39. US & Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Country (2018-2029)
Figure 40. U.S. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2018-2029)
Figure 43. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2018-2029)
Figure 44. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2018-2029)
Figure 45. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Appli

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries